09 October 2020 | News
Santen and Orbis will accelerate the growth of quality eye care systems
Image credit- shutterstock.com
Japanese firm Santen Pharmaceutical and Orbis International in the US have announced a long-term, ten-year partnership to tackle the increasing burden of eye diseases in low- and middle-income countries, especially in Asia.
Under this long-term partnership, Santen and Orbis will accelerate the growth of quality eye care systems by building the capacity of eye care professionals, developing digital technology and increasing awareness of the importance of eye health.
During the initial three years of the ten-year partnership, Santen and Orbis – through Orbis's initiatives and award-winning telemedicine platform, Cybersight, which reaches eye care professionals across 200 countries and regions – will carry out the following activities: